Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT, Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC, Garcia HH, 2004. Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934–1938.
Antoniuk SA, Bruck I, Dos Santos LH, Pintarelli VL, Navolar FB, Brackmann PC Jr, de Morais RL, 2001. Seizures associated with calcifications and edema in neurocysticercosis. Pediatr Neurol 25: 309–311.
Gupta RK, Kumar R, Chawla S, Pradhan S, 2002. Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 43: 1502–1508.
Nash TE, Patronas NJ, 1999. Edema associated with calcified lesions in neurocysticercosis. Neurology 53: 777–781.
Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH, 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099–1105.
Nash TE, Pretell J, Garcia HH, 2001. Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis 33: 1649–1653.
Park SY, Barkovich AJ, Weintraub PS, 2000. Clinical implications of calcified lesions of neurocysticercosis. Pediatr Infect Dis J 19: 581–583.
Poeschl P, Janzen A, Schuierer G, Winkler J, Bogdahn U, Steinbrecher A, 2006. Calcified neurocysticercosis lesions trigger symptomatic inflammation during antiparasitic therapy. AJNR Am J Neuroradiol 27: 653–655.
Sheth TN, Lee C, Kucharczyk W, Keystone J, 1999. Reactivation of neurocysticercosis: case report. Am J Trop Med Hyg 60: 664–667.
Del Brutto OH, 1994. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44: 1706–1709.
Garg RK, Karak B, Mohan Kar A, 1998. Neuroimaging abnormalities in Indian patients with uncontrolled partial seizures. Seizure 7: 497–500.
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, Dickey M, Reynolds S, Stoner JA, 2010. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
Nash T, 2012. Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health 106: 275–279.
Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE, 2011. Short report: a calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg 85: 460–463.
Gupta A, Nadimpalli SP, Cavallino RP, 2002. Intraventricular neurocysticercosis mimicking colloid cyst. Case report. J Neurosurg 97: 208–210.
Wray SD, Ellis TL, Bianco S, 2001. Migratory neurocysticercosis mimicking a third ventricular colloid cyst: case report. J Neurosurg 95: 122–123.
Hennenberg R, 1912. Die tierischen Parasiten des Zentralnervensystems. Lewandowsky M, ed. Handbuch der Neurologie, 642–683.
Escobar A, Weidenheim K, 2002. The pathology of neurocysticercosis. Singh G, Prabhakar S, eds. Taenia solium Cysticercosis: From Basics to Clinical Science. Wallingford, Oxon, UK: CABI Publishing, 289– 305.
Marquez-Monter H, 1971. Cysticercosis. Marcial-Rojas R, ed. Pathology of Protozoal and Helminthic Diseases. Baltimore, MD: Williams & Wilkins Company, 592–617.
Rabiela MT, Rivas A, Flisser A, 1989. Morphological types of Taenia solium cysticerci. Parasitol Today 5: 357–359.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 8 | 8 | 8 |
Full Text Views | 430 | 173 | 6 |
PDF Downloads | 172 | 68 | 8 |
Here, we present the second report of the histopathology of a Taenia solium calcification giving rise to perilesional edema. This has important implications, because if perilesional edema lesions are inflammatory in character, immunosuppressive or anti-inflammatory medications, not just antiepileptic drugs alone, may be useful to prevent or treat recurring episodes in such patients.
Financial support: The support for this study was in part received from the Intramural National Institutes of Allergy and Infectious diseases at the National Institutes of Health.
Authors' addresses: Theodore E. Nash, National Institutes of Health, Laboratory of Parasitic Diseases, Bethesda, MD, E-mails: tnash@niaid.nih.gov or tnash@nih.gov. Luther A. Bartelt, University of Virginia, Infectious Disease, Charlottesville, VA, E-mails: lab2za@virginia.edu or luther.bartelt@gmail.com. Poonum S. Korpe, University of Virginia, Department of Medicine, Charlottesville, VA, E-mail: psk9p@virginia.edu. Beatriz Lopes and Eric R. Houpt, University of Virginia, Pathology, Charlottesville, VA, E-mails: MSL2E@virginia.edu and erh6k@virginia.edu or ERH6K@hscmail.mcc.virginia.edu.